First and Only In-Home Rapid Oral HIV Test Now Available to Consumers Across the U.S.

        Print
| Source: OraSure Technologies, Inc.

A Major Breakthrough in the Fight Against HIV the OraQuick® In-Home HIV Test Now Can Be Purchased at Retailers Nationwide and Online

BETHLEHEM, Pa., Oct. 9, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced the availability of the OraQuick® In-Home HIV Test at retailers nationwide and online, making it the first rapid infectious disease test ever to be made available directly to consumers for in-home use. To mark the launch, the Company is collaborating with a high profile celebrity as part of an ongoing awareness campaign on the importance of knowing your HIV status. Details on the campaign will be shared on a national media webcast on Wednesday, October 10th at 3 p.m. ET.

"For the first time ever, individuals now have access to an in-home rapid oral HIV test – the same test healthcare professionals have used and trusted for years – that will empower them to learn their HIV status in the comfort and privacy of their own home," said Douglas A. Michels, President and Chief Executive Officer of OraSure Technologies. "This is a tremendous breakthrough in our fight against HIV and AIDS."

The OraQuick® In-Home HIV Test detects antibodies to both HIV-1 and HIV-2 with an oral swab, providing a confidential in-home testing option with results in as little as 20 minutes. The in-home test is an over-the-counter version of OraQuick ADVANCE®, an oral swab rapid test with more than 25 million units sold in the professional market, including doctors, hospitals, clinics and other trained professionals. The OraQuick In-Home HIV Test is now available nationwide at more than 30,000 retailers and online and at OraQuick.com.

To ensure optimal support for individuals using the OraQuick® In-Home HIV Test, OraSure is making available specialized resources including live support and comprehensive referral services 24 hours a day, seven days a week, every day of the year, through a toll-free support center and comprehensive consumer website. The OraQuick® Support Center is staffed with highly trained, bi-lingual (English/Spanish) representatives who are available by telephone at 866-436-6527 to answer questions about HIV/AIDS and using and interpreting the test. They also provide referrals to follow-up and care, and they can also take orders for the OraQuick In-Home HIV Test. Additionally, the product website provides access to resources and referral to follow-up counseling, confirmatory testing and medical care.

Visit OraQuick.com for more information.

National Media Webcast

OraSure Technologies will hold a national media webcast to share details on the campaign on Wednesday, October 10 at 3 p.m. Eastern Time. The webcast is intended for media only. To attend the webcast, please log on here five minutes ahead of the Webcast. The meeting number is 596 724 325 and the password is orasure. For audio only, media can use the toll-free line 1-877-481-4772 and enter the conference code 39605844 to join the meeting.  

About OraSure Technologies

OraSure Technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its innovative products include rapid tests for the detection of antibodies to HIV and HCV at the point of care and testing solutions for detecting various drugs of abuse. In July 2012, the Company received approval from the U.S. Food and Drug Administration for the Company's OraQuick® In-Home HIV Test for sale directly to consumers in the over-the-counter (OTC) market – making it the first and only rapid OTC HIV test approved in the U.S. In addition, the Company is a leading provider of oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, and commercial and industrial entities. The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health. 

For more information on OraSure Technologies, please visit www.orasure.com.

The OraSure Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6440

Investor Contact:
Ronald H. Spair
Chief Financial Officer
610-882-1820


Media Contact:
Ashley Buford
GolinHarris for OraSure Technologies
917-653-5694